Corix Bioscience (Corix Bioscience) Operating Cash Flow per Share : $-0.19 (TTM As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Operating Cash Flow per Share?

Corix Bioscience's operating cash flow per share for the three months ended in Sep. 2017 was $-0.08. Corix Bioscience's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2017 was $-0.19.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Corix Bioscience's Operating Cash Flow per Share or its related term are showing as below:

CXBS's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.55
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Corix Bioscience Operating Cash Flow per Share Historical Data

The historical data trend for Corix Bioscience's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Operating Cash Flow per Share Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Operating Cash Flow per Share

Get a 7-Day Free Trial

-120.00

-0.28

-0.22

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.06	-0.04	-0.03	-0.04	-0.08

Competitive Comparison of Corix Bioscience's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Price-to-Operating-Cash-Flow falls into.

Corix Bioscience Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Corix Bioscience's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2016 is calculated as

Operating Cash Flow per Share (A: Dec. 2016 )	=	Cash Flow from Operations (A: Dec. 2016 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2016 )
	=	-1.849	/	8.527
	=	-0.22

Corix Bioscience's Operating Cash Flow per Share for the quarter that ended in Dec. 2016 is calculated as

Operating Cash Flow per Share (Q: Sep. 2017 )	=	Cash Flow from Operations (Q: Sep. 2017 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2017 )
	=	-1.722	/	20.515
	=	-0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.19

Corix Bioscience Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines